Henry Fok

Henry Fok has extensive work experience in the field of clinical science. Henry is currently serving as a Senior Director of Clinical Science at Silence Therapeutics plc since July 2022. Prior to this, they held roles as an Honorary Senior Clinical Lecturer at King's College London from May 2020 to July 2022, a Clinical Senior Lecturer at St George's, University of London from September 2019 to July 2022, and a Consultant in Clinical Pharmacology at Guy's and St Thomas' NHS Foundation Trust from August 2018 to July 2022.

Henry Fok has an extensive education history in the field of medicine. From 2000 to 2006, they attended Queen Mary University of London where they obtained their MBBS degree. In 2004 and 2005, they pursued further studies at the same university and earned a BMedSci degree in Molecular Therapeutics. Henry Fok then moved on to pursue a diploma in child health at the Royal College of Paediatrics and Child Health from 2012 to 2013. In 2009, they attended the Royal College of Physicians where they obtained a MRCP qualification. Finally, Henry Fok completed their education with a Doctor of Philosophy (PhD) degree in Medicine from King's College London, which they achieved from 2010 to 2015.